Italian companies
Pharma, biotech, medical devices, and healthcare service providers: typically family- or founder-controlled.
Industry
Life Sciences, medical devices, digital health.
Specialty pharma, medical devices, diagnostics, digital health, and biotech are heavily regulated, R&D-intensive businesses, where consolidation is driven by international players. Montesino advises entrepreneurs on sales to international pharma groups and healthcare funds, and works with PE funds on build-ups in the Italian mid-market.
Who it's for
Italian companies, specialized funds, and big pharma operate in a sector that is concentrating across Europe.
Pharma, biotech, medical devices, and healthcare service providers: typically family- or founder-controlled.
Healthcare-focused PE and biotech venture capital active in the European mid-market for acquisitions, exits, and scale-up transactions.
Big pharma, international medical device groups, and digital health operators seeking Italian assets with distinctive positioning.
What we do
Value depends on the product, the pipeline, and the regulatory framework. Montesino has access to investors specialized in the sector.
Sell-side advisory for founders and families toward big pharma or medical device groups.
Rounds for scale-up operators, from Series A to growth.
Structuring of commercial agreements with corporate implications (royalties, milestones, equity).
Coordination of complex deals with international counterparties and multiple regulators.
Industry insight
REPORT
NOTE
ARTICLE
REPORT
The team
Chartered accountant since 1993, court-appointed expert (CTU) at the Tribunal of Milano (Milan). Cross-border M&A negotiations.
Managing Partner
Thirty years in business management, combining direct entrepreneurial activity and management consulting. CFO and executive committee member at companies in metals and mechanics, chemicals, agriculture and services.
Managing Partner
Business development and SME internationalization.